: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)

Free Medical Books

HIV Infection

Free Subscription

Articles published in J Virol
Retrieve available abstracts of 310 articles:
HTML format
Text format

Single Articles

May 2012

DOEHLE BP , Chang K, Rustagi A, McNevin J, et al
Vpu mediates IRF3 depletion during HIV infection by a lysosomal-dependent mechanism.
J Virol. 2012.
PubMed Text format Related articles Abstract available

KEENE SE , Telesnitsky A
Cis-acting determinants of 7SL RNA packaging by HIV-1.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LIU J , Li H, Iampietro MJ, Barouch DH, et al
Accelerated Heterologous Adenovirus Prime-Boost SIV Vaccine in Neonatal Rhesus Monkeys.
J Virol. 2012.
PubMed Text format Related articles Abstract available

GONZALEZ-HERNANDEZ MJ , Swanson MD, Contreras-Galindo R, Cookinham S, et al
Expression of Human Endogenous Retrovirus Type-K (HML-2) is activated by the Tat protein of HIV-1.
J Virol. 2012.
PubMed Text format Related articles Abstract available

FLATZ L , Cheng C, Wang L, Foulds K, et al
Gene-based vaccination with a mis-matched envelope protects against simian immunodeficiency virus infection in non-human primates.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LYNCH RM , Tran L, Louder MK, Schmidt SD, et al
The Development of CD4 Binding Site Antibodies During HIV-1 Infection.
J Virol. 2012.
PubMed Text format Related articles Abstract available

BUDDE ML , Greene JM, Chin EN, Ericsen AJ, et al
Specific CD8+ T Cell Responses Correlate with Control of SIV Replication in Mauritian Cynomolgus Macaques.
J Virol. 2012.
PubMed Text format Related articles Abstract available

JACOB RA , Abrahams F, Tongo M, Schomaker M, et al
Refined identification of neutralization-resistant HIV-1 CRF02_AG viruses.
J Virol. 2012.
PubMed Text format Related articles Abstract available

FRANSEN S , Gupta S, Frantzell A, Petropoulos CJ, et al
Substitutions at Amino Acid Positions 143, 148 and 155 of HIV-1 Integrase Define Distinct Genetic Barriers to Raltegravir Resistance in vivo.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MIR KD , Bosinger SE, Gasper M, Ho O, et al
SIV-INDUCED ALTERATIONS IN MONOCYTE TNF-alpha PRODUCTION CONTRIBUTE TO REDUCED IMMUNE ACTIVATION IN SOOTY MANGABEYS.
J Virol. 2012.
PubMed Text format Related articles Abstract available

YANG L , Song Y, Li X, Huang X, et al
HIV-1 Virus Like Particles Produced by Stably Transfected Drosophila S2 cells - a Desirable Vaccine Component.
J Virol. 2012.
PubMed Text format Related articles Abstract available

DURHAM ND , Yewdall AW, Chen P, Lee R, et al
Neutralization resistance of HIV-1 virological synapse-mediated infection is regulated by the gp41 cytoplasmic tail.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MOODY MA , Yates NL, Amos JD, Drinker MS, et al
HIV-1 gp120 Vaccine Induces Affinity Maturation in Both New and Persistent Antibody Clonal Lineages.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LEWIS MJ , Dagarag M, Khan B, Ali A, et al
Partial Escape of HIV-1 From Cytotoxic T Lymphocytes During Chronic Infection.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LEWIS MJ , Lee P, Ng HL, Yang OO, et al
IMMUNE SELECTION IN VITRO REVEALS HUMAN IMMUNODEFICIENCY VIRUS-1 NEF SEQUENCE MOTIFS IMPORTANT FOR ITS IMMUNE EVASION FUNCTION IN VIVO.
J Virol. 2012.
PubMed Text format Related articles Abstract available

April 2012

ROTHAEUSLER K , Ma ZM, Qureshi H, Carroll TD, et al
Antiviral antibodies and T cells are present in the foreskin of SIV-infected rhesus macaques.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MITSUKI YY , Terahara K, Shibusawa K, Yamamoto T, et al
HIV-1 infection ex vivo accelerates measles virus infection by upregulating signaling lymphocytic activation molecule (SLAM) in CD4+ T cells.
J Virol. 2012.
PubMed Text format Related articles Abstract available

YEH WW , Brassard LM, Miller CA, Basavapathruni A, et al
Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeys.
J Virol. 2012.
PubMed Text format Related articles Abstract available

NDHLOVU ZM , Proudfoot J, Cesa K, Alvino DM, et al
Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.
J Virol. 2012.
PubMed Text format Related articles Abstract available

WANG YX , Luo C, Zhao D, Beck J, et al
Extensive mutagenesis of the conserved box E motif in duck hepatitis B virus P protein reveals multiple functions in replication and a common structure with the primer grip in HIV-1 reverse transcriptase.
J Virol. 2012.
PubMed Text format Related articles Abstract available

CELESTINO M , Calistri A, Del Vecchio C, Salata C, et al
Feline tetherin is characterized by a short N-terminal region and is counteracted by the Feline Immunodeficiency virus envelope glycoprotein.
J Virol. 2012.
PubMed Text format Related articles Abstract available

FREEL SA , Picking RA, Ferrari G, Ding H, et al
Initial HIV- 1 Antigen-specific CD8+ T cells In Acute HIV-1 Inhibit Transmitted Founder Virus Replication.
J Virol. 2012.
PubMed Text format Related articles Abstract available

KWON DS , Angin M, Hongo T, Law KM, et al
CD4+ CD25+ Regulatory T cells Impair HIV-Specific CD4 T Cell Responses by Upregulating IL-10 Production in Monocytes.
J Virol. 2012.
PubMed Text format Related articles Abstract available

BROCKMAN MA , Chopera DR, Olvera A, Brumme CJ, et al
Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LEMKE CT , Titolo S, von Schwedler U, Goudreau N, et al
Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
J Virol. 2012.
PubMed Text format Related articles Abstract available

THOBAKGALE CF , Fadda L, Lane K, Toth I, et al
Frequent and Strong Antibody-Mediated Natural Killer Cell Activation to HIV-1 Env in Individuals with Chronic HIV-1 Infection.
J Virol. 2012.
PubMed Text format Related articles Abstract available

TSIBRIS AM , Hu Z, Paredes R, Leopold KE, et al
Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates Under Sequential Drug Selection Pressures.
J Virol. 2012.
PubMed Text format Related articles Abstract available

CHIUPPESI F , Vannucci L, De Luca A, Lai M, et al
A lentiviral vector-based, herpes simplex virus type-1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.
J Virol. 2012.
PubMed Text format Related articles Abstract available

NOMURA T , Yamamoto H, Shiino T, Takahashi N, et al
Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in Burmese rhesus macaques.
J Virol. 2012.
PubMed Text format Related articles Abstract available

ALI MM , Karasneh GA, Jarding MJ, Tiwari V, et al
A 3-O Sulfated Heparan Sulfate Binding Peptide Preferentially Targets Herpes Simplex Virus Type-2 Infected Cells.
J Virol. 2012.
PubMed Text format Related articles Abstract available

PERREAU M , Welles HC, Pellaton C, Gjoksi B, et al
The Number of TLR9-Agonist Motifs in the Adenovirus Genome Correlates with Induction of DC Maturation by Adenovirus Immune Complexes.
J Virol. 2012.
PubMed Text format Related articles Abstract available

March 2012

OOMS M , Krikoni A, Kress AK, Simon V, et al
APOBEC3A, APOBEC3B and APOBEC3H haplotype 2 restrict Human T-lymphotropic virus type I (HTLV-1).
J Virol. 2012.
PubMed Text format Related articles Abstract available

MOLDT B , Shibata-Koyama M, Rakasz EG, Schultz N, et al
A non-fucosylated variant of the anti-HIV-1 MAb b12 has enhanced FcgammaRIIIa-mediated antiviral activity in vitro but not improved protection against mucosal SHIV challenge in macaques.
J Virol. 2012.
PubMed Text format Related articles Abstract available

FISHER R , van Zyl GU, Travers SA, Kosakovsky Pond SL, et al
Deep sequencing reveals minor protease resistance mutants in patients failing a protease inhibitor regimen.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MUNSHAW S , Bailey JR, Liu L, Osburn W, et al
Computational Reconstruction of Bole1a, a Representative Synthetic Hepatitis C Subtype 1a Viral Genome.
J Virol. 2012.
PubMed Text format Related articles Abstract available

BOYER PL , Clark PK, Hughes SH
HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors.
J Virol. 2012.
PubMed Text format Related articles Abstract available

YAMAMOTO T , Johnson MJ, Price DA, Wolinsky DI, et al
Virus inhibition activity of effector memory CD8+ T cells determines Simian Immunodeficiency Virus load in vaccinated monkeys after vaccine breakthrough infection.
J Virol. 2012.
PubMed Text format Related articles Abstract available

WU X , Wang C, O'Dell S, Li Y, et al
Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site.
J Virol. 2012.
PubMed Text format Related articles Abstract available

GOMEZ CE , Perdiguero B, Najera JL, Sorzano CO, et al
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice.
J Virol. 2012.
PubMed Text format Related articles Abstract available

L'HERNAULT A , Weiss EU, Greatorex JS, Lever AM, et al
HIV-2 genome dimerisation is required for the correct processing of Gag: a second-site reversion in Matrix can restore both processes in dimerisation impaired mutant viruses.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LICHTERFELD M , Cung T, Seiss K, Rosenberg ES, et al
Shelterin dysfunction and p16INK4a-mediated growth inhibition in HIV-1-specific CD8 T cells.
J Virol. 2012.
PubMed Text format Related articles Abstract available

WALKER JE , Chen RX, McGee J, Nacey C, et al
Generation of an HIV-1 resistant immune system with CD34+ HSCs transduced with a triple combination anti-HIV lentiviral vector.
J Virol. 2012.
PubMed Text format Related articles Abstract available

VALLE-CASUSO JC , Di Nunzio F, Yang Y, Reszka N, et al
TNPO3 is Required for HIV-1 Replication After Nuclear Import but Prior to Integration and Binds the HIV-1 Core.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LOPEZ LA , Yang SJ, Exline CM, Rengarajan S, et al
Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve tetherin removal from lipid rafts.
J Virol. 2012.
PubMed Text format Related articles Abstract available

February 2012

SAJADI MM , Lewis GK, Seaman MS, Guan Y, et al
Signature Biochemical Properties of Broadly Cross-Reactive HIV-1 Neutralizing Antibodies in Human Plasma.
J Virol. 2012.
PubMed Text format Related articles Abstract available

GOMEZ CORREDOR A , Archambault D
The bovine immunodeficiency virus Rev protein: identification of novel nuclear import pathway and nuclear export signal among retroviral Rev/Rev-like proteins.
J Virol. 2012.
PubMed Text format Related articles Abstract available

SHAMAY M , Liu J, Li R, Liao G, et al
A Protein Array Screen for KSHV LANA Interactors Links LANA to TIP60, PP2A activity and Telomere Shortening.
J Virol. 2012.
PubMed Text format Related articles Abstract available

ZUO T , Liu D, Lv W, Wang X, et al
Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Replication by Targeting of the Interaction between Vif and ElonginC.
J Virol. 2012.
PubMed Text format Related articles Abstract available

CARLSON JM , Listgarten J, Pfeifer N, Tan V, et al
Widespread Impact of HLA Restriction on Immune Control and Escape Pathways in HIV-1.
J Virol. 2012.
PubMed Text format Related articles Abstract available

ACOSTA-HOYOS AJ , Matsuura SE, Meyer PR, Scott WA, et al
A Role of Template Cleavage in Reduced Excision of Chain-Terminating Nucleotides by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing the M184V Mutation.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MUFHANDU HT , Gray ES, Madiga MC, Tumba N, et al
UCLA1, a Synthetic Derivative of a gp120 RNA Aptamer, Inhibits Entry of Human Immunodeficiency Virus Type-1 Subtype C.
J Virol. 2012.
PubMed Text format Related articles Abstract available

AHSAN MH , Gill AF, Lackner AA, Veazey RS, et al
Acute and chronic T cell dynamics in the liver of SIV infected macaques.
J Virol. 2012.
PubMed Text format Related articles Abstract available

SATO K , Misawa N, Fukuhara M, Iwami S, et al
Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice.
J Virol. 2012.
PubMed Text format Related articles Abstract available

FALKOWSKA E , Ramos A, Feng Y, Zhou T, et al
PG V04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.
J Virol. 2012.
PubMed Text format Related articles Abstract available

BOUCHET J , Herate C, Guenzel C, Verollet C, et al
Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions.
J Virol. 2012.
PubMed Text format Related articles Abstract available

KHALID M , Yu H, Sauter D, Usmani SM, et al
Efficient Nef-Mediated Down-modulation of TCR-CD3 and CD28 is Associated with High CD4+ T Cell Counts in Viremic HIV-2 Infection.
J Virol. 2012.
PubMed Text format Related articles Abstract available

DRANNIK AG , Nag K, Yao XD, Henrick BM, et al
Anti-HIV-1 Activity of Elafin is More Potent than Its Precursor's Trappin-2 in Genital Epithelial Cells.
J Virol. 2012.
PubMed Text format Related articles Abstract available

BELLO NF , Dussupt V, Sette P, Rudd V, et al
Budding of Retroviruses Utilizing Divergent L domains Requires Nucleocapsid.
J Virol. 2012.
PubMed Text format Related articles Abstract available

WOLSCHENDORF F , Bosque A, Shishido T, Duverger A, et al
Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-kappaB activity.
J Virol. 2012.
PubMed Text format Related articles Abstract available

XIAO P , Patterson LJ, Kuate S, Brocca-Cofano E, et al
Replicating adenovirus-SIV recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low dose rectal SIVmac251 challenge.
J Virol. 2012.
PubMed Text format Related articles Abstract available

PARSONS MS , Wren L, Isitman G, Navis M, et al
HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
J Virol. 2012.
PubMed Text format Related articles Abstract available

BLAZKOVA J , Murray D, Justement JS, Funk EK, et al
Paucity of HIV DNA Methylation in Latently Infected, Resting CD4+ T Cells from Infected Individuals Receiving Antiretroviral Therapy.
J Virol. 2012.
PubMed Text format Related articles Abstract available

BALUYOT MF , Grosse SA, Lyddon TD, Janaka SK, et al
CRM1-dependent trafficking of retroviral Gag proteins revisited.
J Virol. 2012.
PubMed Text format Related articles Abstract available

VOJNOV L , Martins MA, Bean AT, Veloso de Santana MG, et al
The majority of freshly sorted SIV-specific CD8+ T cells cannot suppress viral replication in SIV-infected macrophages.
J Virol. 2012.
PubMed Text format Related articles Abstract available

KNUDSEN ML , Mbewe-Mvula A, Rosario M, Johansson DX, et al
Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to conventional plasmid DNA vaccine.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MACHMACH K , Leal M, Gras C, Viciana P, et al
Plasmacytoid Dendritic Cells Reduce HIV Production in Elite Controllers.
J Virol. 2012.
PubMed Text format Related articles Abstract available

HATFULL GF
Complete Genome Sequences of 138 Mycobacteriophages.
J Virol. 2012;86:2382-2384.
PubMed Text format Related articles Abstract available

WANG X , Ao Z, Chen L, Kobinger G, et al
The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MATUSALI G , Potesta M, Santoni A, Cerboni C, et al
The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Down-regulate The Natural Killer Cell Activating Ligand PVR.
J Virol. 2012.
PubMed Text format Related articles Abstract available

DIOMEDE L , Nyoka S, Pastori C, Scotti L, et al
Passively transmitted gp41 antibodies in babies born from subtype C HIV-1 seropositive women: correlation between fine specificity and protection.
J Virol. 2012.
PubMed Text format Related articles Abstract available

BONSIGNORI M , Montefiori DC, Wu X, Chen X, et al
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-infected Donor: Implications for Vaccine Design.
J Virol. 2012.
PubMed Text format Related articles Abstract available

AMBROSE Z , Lee K, Ndjomou J, Xu H, et al
Human Immunodeficiency Virus Type 1 (HIV-1) Capsid Mutation N74D Alters Cyclophilin A Dependence and Impairs Macrophage Infection.
J Virol. 2012.
PubMed Text format Related articles Abstract available

TONG T , Crooks ET, Osawa K, Binley JM, et al
HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Non-Neutralizing Epitopes.
J Virol. 2012.
PubMed Text format Related articles Abstract available

IIJIMA S , Lee YJ, Ode H, Arold S, et al
A non-canonical mu-1A-binding motif in the N-terminus of HIV-1 Nef determines its activity to down-regulate MHC-I in T lymphocytes.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LEE K , Mulky A, Yuen W, Martin TD, et al
HIV-1 Capsid Targeting Domain of Cleavage and Polyadenylation Specificity Factor 6.
J Virol. 2012.
PubMed Text format Related articles Abstract available

January 2012

FERRANDO-MARTINEZ S , Casazza JP, Leal M, Machmach K, et al
Differential gag-specific polyfunctional T cell maturation patterns in HIV-1 Elite Controllers.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LI X , Koh Y, Engelman A
Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MENDOZA D , Royce C, Ruff LE, Ambrozak DR, et al
HLA B*5701+ Long-Term Nonprogressors/Elite Controllers are not Distinguished from Progressors by the Clonal Composition of HIV-Specific CD8+ T-Cells.
J Virol. 2012.
PubMed Text format Related articles Abstract available

WILLER DO , Ambagala AP, Pilon R, Chan JK, et al
Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with human Varicella Zoster Virus (VZV).
J Virol. 2012.
PubMed Text format Related articles Abstract available

USAMI Y , Popov S, Weiss ER, Vriesema-Magnuson C, et al
Regulation of CHMP4/ESCRT-III Function in Human Immunodeficiency Virus Type 1 Budding by CC2D1A.
J Virol. 2012.
PubMed Text format Related articles Abstract available

DORIA-ROSE NA , Louder MK, Yang Z, O'Dell S, et al
HIV-1 Neutralization Coverage Is Improved by Combining Monoclonal Antibodies That Target Independent Epitopes.
J Virol. 2012.
PubMed Text format Related articles Abstract available

GALLASTEGUI E , Marshall B, Vidal D, Sanchez-Duffhues G, et al
Combination of biological screening in a cellular model of viral latency with virtual screening identifies novel compounds that reactivate HIV-1.
J Virol. 2012.
PubMed Text format Related articles Abstract available

GREWE B , Hoffmann B, Ohs I, Blissenbach M, et al
Cytoplasmic utilization of Human Immunodeficiency Virus type 1 genomic RNA is not dependent on a nuclear interaction with Gag.
J Virol. 2012.
PubMed Text format Related articles Abstract available

CONRAD JA , Ramalingam RK, Duncan CB, Smith RM, et al
Anti-retroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MONEL B , Beaumont E, Vendrame D, Schwartz O, et al
HIV cell-to-cell transmission requires the production of infectious virus particles, and does not proceed through Env-mediated fusion pores.
J Virol. 2012.
PubMed Text format Related articles Abstract available

LONG BR , Stoddart CA
Interferon alpha and HIV Infection Cause Activation of Human T Cells in NSG-BLT Mice.
J Virol. 2012.
PubMed Text format Related articles Abstract available

WRIGHT JK , Naidoo VL, Brumme ZL, Prince JL, et al
The impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
J Virol. 2012.
PubMed Text format Related articles Abstract available

MONTERO M , Gulzar N, Klaric KA, Donald JE, et al
Neutralizing Epitopes in the MPER of HIV-1 gp41 Are Influenced by the Transmembrane Domain and the Plasma Membrane.
J Virol. 2012.
PubMed Text format Related articles Abstract available

DONAHUE DA , Kuhl BD, Sloan RD, Wainberg MA, et al
The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency.
J Virol. 2012.
PubMed Text format Related articles Abstract available

December 2011

CHIANG K , Sung TL, Rice AP
Regulation of Cyclin T1 and HIV-1 Replication by miRNAs in Resting CD4+ T Lymphocytes.
J Virol. 2011.
PubMed Text format Related articles Abstract available

HULTQUIST JF , Binka M, Larue RS, Simon V, et al
Vif Proteins of Human and Simian Immunodeficiency Viruses Require Cellular CBFbeta to Degrade APOBEC3 Restriction Factors.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KOPPENSTEINER H , Banning C, Schneider C, Hohenberg H, et al
Macrophage internal HIV-1 is protected from neutralizing antibodies.
J Virol. 2011.
PubMed Text format Related articles Abstract available

QUASHIE PK , Mesplede T, Han Y, Oliveira M, et al
Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor Dolutegravir.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MELCHERS M , Bontjer I, Tong T, Chung NP, et al
Targeting HIV-1 envelope glycoprotein trimers to B cells using APRIL improves antibody responses.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TUGIZOV SM , Herrera R, Veluppillai P, Greenspan D, et al
Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia.
J Virol. 2011.
PubMed Text format Related articles Abstract available

OCHSENBAUER C , Edmonds TG, Ding H, Keele BF, et al
Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of their Replication Capacity in CD4 T-Lymphocytes and Monocyte-derived Macrophages.
J Virol. 2011.
PubMed Text format Related articles Abstract available

FADEL HJ , Saenz DT, Guevara R, von Messling V, et al
Productive Replication and Evolution of HIV-1 in Ferret Cells.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WEINBERG A , Huang S, Song LY, Fenton T, et al
IMMUNE CORRELATES OF HERPES ZOSTER IN HIV-INFECTED CHILDREN AND YOUTH.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GUENZEL CA , Herate C, Le Rouzic E, Maidou-Peindara P, et al
Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MAZUROV D , Ilinskaya A, Heidecker G, Filatov A, et al
The role of O-glycosylation and expression of CD43 and CD45 on the surface of effector T cells in HTLV-1 cell-to-cell infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SCHMID M , Gonzalez RA, Dobner T
CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.
J Virol. 2011.
PubMed Text format Related articles Abstract available

AKAHOSHI T , Chikata T, Tamura Y, Gatanaga H, et al
Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific CTLs recognizing wild-type and/or escape mutant epitopes.
J Virol. 2011.
PubMed Text format Related articles Abstract available

NARASIPURA SD , Henderson LJ, Fu S, Chen L, et al
Role of beta-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LAVINE CL , Lao S, Montefiori DC, Haynes BF, et al
High-Mannose Glycan-Dependent Epitopes Are Frequently Targeted in Broad Neutralizing Antibody Responses during Infection of Human Immunodeficiency Virus Type 1.
J Virol. 2011.
PubMed Text format Related articles Abstract available

EULER Z , van den Kerkhof TL, van Gils MJ, Burger JA, et al
Longitudinal analysis of early HIV-1 specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity.
J Virol. 2011.
PubMed Text format Related articles Abstract available

QURESHI H , Ma ZM, Huang Y, Hodge G, et al
Low dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus 5 then immunized with a replication defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the Phase IIb Step trial of a similar HIV-1 vaccine.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BRANDANO L , Stevenson M
A Highly Conserved Residue in the C-Terminal Helix of HIV-1 Matrix is Required for Envelope Incorporation into Virus Particles.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WANG J , Zhang W, Lv M, Zuo T, et al
Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
J Virol. 2011;85:12482-91.
PubMed Text format Related articles Abstract available

November 2011

HAMMONDS J , Ding L, Chu H, Geller K, et al
The Tetherin/BST-2 Coiled-Coil Ectodomain Mediates Plasma Membrane Microdomain Localization and Restriction of Particle Release.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GIANELLA S , Strain MC, Rought SE, Vargas MV, et al
Associations between the Virologic and Immunologic Dynamics in Blood and in the Male Genital Tract.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ROA A , Hayashi F, Yang Y, Lienlaf M, et al
RING Domain Mutations Uncouple TRIM5alpha Restriction of HIV-1 From Inhibition of Reverse Transcription and Acceleration of Uncoating.
J Virol. 2011.
PubMed Text format Related articles Abstract available

RATHINAKUMAR R , Dutta M, Zhu P, Johnson WE, et al
Binding of anti-membrane proximal gp41 monoclonal antibodies to CD4-liganded and unliganded HIV-1 and SIV virions.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LIETZ R , Bayer W, Ontikatze T, Johrden L, et al
Co-delivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CHEN Z , Kolokoltsov AA, Wang J, Adhikary S, et al
GRB2 interaction with the ecotropic murine leukemia virus receptor, mCAT-1, controls virus entry and is stimulated by virus binding.
J Virol. 2011.
PubMed Text format Related articles Abstract available

PUTCHAROEN O , Lee SH, Henrich TJ, Hu Z, et al
HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics that Correct in the Presence of Drug.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WRIGHT JK , Brumme ZL, Julg B, van der Stok M, et al
Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals.
J Virol. 2011.
PubMed Text format Related articles Abstract available

VEERANNA RP , Haque M, Davis DA, Yang M, et al
KSHV latency-associated nuclear antigen (LANA) induction by hypoxia and hypoxia-inducible factors (HIF).
J Virol. 2011.
PubMed Text format Related articles Abstract available

ARNOLD F , Schnell J, Zirafi O, Sturzel C, et al
Naturally Occurring Fragments from Two Distinct Regions of the Prostatic Acid Phosphatase Form Amyloidogenic Enhancers of HIV Infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KLOVERPRIS HN , Stryhn A, Harndahl M, van der Stok M, et al
HLA-B*57 micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure and HIV immune control.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KLATT NR , Canary LA, Vanderford TH, Vinton CL, et al
Dynamics of SIVmac239 infection in Pigtail Macaques.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MAGADAN JG , Bonifacino JS
Transmembrane Domain Determinants of CD4 Downregulation, by HIV-1 Vpu.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ISHII H , Kawada M, Tsukamoto T, Yamamoto H, et al
Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques.
J Virol. 2011.
PubMed Text format Related articles Abstract available

OZKAYA SAHIN G , Holmgren B, da Silva Z, Nielsen J, et al
POTENT INTRATYPE NEUTRALIZING ACTIVITY DISTINGUISHES HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 FROM HUMAN IMMUNODEFICIENCY VIRUS TYPE 1.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MARSDEN MD , Kovochich M, Suree N, Shimizu S, et al
HIV latency in the humanized BLT mouse.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SALSMAN J , Jagannathan M, Paladino P, Chan PK, et al
Proteomic Profiling of the Human Cytomegalovirus UL35 Gene Products Reveals a Role for UL35 in the DNA Repair Response.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DOBARD C , Sharma S, Martin A, Pau CP, et al
Durable protection from vaginal SHIV infection in macaques by tenofovir gel and its relationship to tissue drug levels.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DE SILVA TI , Aasa-Chapman M, Cotten M, Hue S, et al
Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.
J Virol. 2011.
PubMed Text format Related articles Abstract available

POSTLER TS , Martinez-Navio JM, Yuste E, Desrosiers RC, et al
Evidence Against Extracellular Exposure of a Highly Immunogenic Region in the C-Terminal Domain of the SIVmac gp41 Transmembrane Protein.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LUO M , Daniuk CA, Diallo TO, Capina RE, et al
For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

October 2011

SELLHORN G , Kraft Z, Caldwell Z, Ellingson K, et al
Engineering, expression, purification and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KONG R , Li H, Bibollet-Ruche F, Decker JM, et al
Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CONTRERAS-GALINDO RA , Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez M, et al
Characterization of Human Endogenous Retroviral Elements in the Blood of HIV-1-Infected Individuals.
J Virol. 2011.
PubMed Text format Related articles Abstract available

RANASINGHE S , Flanders M, Cutler S, Soghoian DZ, et al
HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome.
J Virol. 2011.
PubMed Text format Related articles Abstract available

YU X , Lu L, Cai L, Tong P, et al
Mutations of Gln64 in the HIV-1 gp41 N-terminal heptad repeat render viruses resistant to peptide HIV fusion inhibitors targeting gp41 pocket.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SPECHT A , Schindler M, Gnanadurai CW, Leonard JA, et al
Down-modulation of CD8{alpha}ss is a fundamental activity of primate lentiviral Nef proteins.
J Virol. 2011.
PubMed Text format Related articles Abstract available

O'CONNOR SL , Becker EA, Weinfurter JT, Chin EN, et al
Conditional CD8+ T cell escape during acute simian immunodeficiency virus infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DENTON PW , Olesen R, Choudhary SK, Archin NM, et al
Generation of HIV Latency in BLT Humanized Mice.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WEST AP JR , Galimidi RP, Gnanapragasam PN, Bjorkman PJ, et al
Single chain Fv-based anti-HIV proteins: Potential and Limitations.
J Virol. 2011.
PubMed Text format Related articles Abstract available

COSNEFROY O , Tocco A, Lesbats P, Thierry S, et al
Stimulation of hRAD51 nucleofilament restricts HIV-1 integration in vitro and in infected cells.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SHELTON MN , Huang MB, Ali SA, Powell MD, et al
SMR-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BINKA M , Ooms M, Steward M, Simon V, et al
The activity spectrum of Vif from multiple HIV-1 Subtypes against APOBEC3G, APOBEC3F and APOBEC3H.
J Virol. 2011.
PubMed Text format Related articles Abstract available

VACCARI M , Boasso A, Fenizia C, Fuchs D, et al
Fatal pancreatitis in SIVmac251 infected macaques treated with 2' ,3' -dideoxyinosine (ddI) and 2' didehydro-3' deoxythymidine(d4T) following CTLA-4 and IDO blockade.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CHOUDHARY S , Archin N, Cheema M, Dahl N, et al
Latent HIV-1 Infection of Resting CD4+ T Cells in the Humanized Rag2-/-{gamma}c-/- Mouse.
J Virol. 2011.
PubMed Text format Related articles Abstract available

JURGENS CK , Young K, Madden VJ, Johnson PR, et al
A Novel Self-Replicating Chimeric Lentivirus-Like Particle.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BURWITZ BJ , Sacha JB, Reed JS, Newman LP, et al
Pyrosequencing Reveals Restricted Patterns of CD8+ T Cell Escape-Associated Compensatory Mutations in SIV.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GUMBI PP , Jaumdally SZ, Salkinder AL, Burgers WA, et al
CD4 T cell depletion at the cervix during HIV infection is associated with accumulation of terminally differentiated T cells.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MARSH AK , Willer DO, Ambagala AP, Dzamba M, et al
Genomic Sequencing and Characterization of Cynomolgus Macaque Cytomegalovirus.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WANG W , De Feo CJ, Zhuang M, Vassell R, et al
Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of human immunodeficiency virus type 1 (HIV-1) gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first
J Virol. 2011.
PubMed Text format Related articles Abstract available

LEWIS G , Fouts T, Ibrahim S, Taylor B, et al
Identification and Characterization of an Immunogenic Hybrid Epitope Formed by Both HIV Gp120 and Human CD4 Proteins.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BALLWEBER L , Robinson B, Kreger A, Fialkow M, et al
Vaginal Langerhans cells non-productively transporting HIV-1 mediate infection of T cells.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LOGUE EC , Taylor KT, Goff PH, Landau NR, et al
The cargo-binding domain of transportin 3 is required for lentivirus nuclear import.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KRACHMAROV C , Lai Z, Honnen WJ, Salomon A, et al
Characterization of structural features and diversity of variable-region determinants of related quaternary epitopes recognized by human and rhesus macaque monoclonal antibodies possessing unusually potent neutralizing activities.
J Virol. 2011;85:10730-40.
PubMed Text format Related articles Abstract available

RUDICELL RS , Piel AK, Stewart F, Moore DL, et al
High prevalence of simian immunodeficiency virus infection in a community of savanna chimpanzees.
J Virol. 2011;85:9918-28.
PubMed Text format Related articles Abstract available

September 2011

WATKINS JD , Diaz-Rodriguez J, Siddappa NB, Corti D, et al
Neutralization Efficiency of Neutralizing Antibodies Targeting the CD4-Binding Site: Influence of Conformational Masking by the V2 Loop in R5-Tropic Clade C SHIV.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MUDD PA , Ericsen AJ, Walsh AD, Leon EJ, et al
CD8+ T cell escape mutations in SIVmac239 cause fitness defects in vivo and many revert after transmission.
J Virol. 2011.
PubMed Text format Related articles Abstract available

YU D , Jin C, Leja J, Majdalani N, et al
Adenovirus with hexon Tat-PTD modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors.
J Virol. 2011.
PubMed Text format Related articles Abstract available

PHAM TN , Richard J, Gerard FC, Power C, et al
Modulation of NKG2D-Mediated Cytotoxic Functions of Natural Killer Cells by Viral Protein R (Vpr) from HIV-1 Primary Isolates.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KONING FA , Goujon C, Bauby H, Malim MH, et al
Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ENGELAND CE , Oberwinkler H, Schumann M, Krause E, et al
The cellular protein Lyric interacts with HIV-1 Gag.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CRAWFORD TQ , Ndhlovu LC, Tan A, Carvidi A, et al
HIV-1 Infection Abrogates CD8+ T Cell MAPK Signaling Responses.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WHITE TA , Bartesaghi A, Borgnia MJ, de la Cruz MJ, et al
3D structures of sCD4-bound states of trimeric SIV envelope glycoproteins determined using cryo-electron tomography.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SANGHVI VR , Steel LF
The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of PKR.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LI W , Green WR
Immunotherapy of murine retrovirus-induced acquired immunodeficiency by CD4 T regulatory cell depletion and PD-1 blockade.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BATTIVELLI E , Migraine J, Lecossier D, Yeni P, et al
Gag CTL Escape Mutations Can Increase Sensitivity of HIV-1 to Human TRIM5{alpha}, Linking Intrinsic and Acquired Immunity.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ALAM SM , Liao HX, Dennison SM, Jaeger F, et al
Differential reactivity of germline allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MIYAGI E , Andrew A, Kao S, Yoshida T, et al
Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin+ cells.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LI H , Liu J, Carville A, Mansfield KG, et al
Durable, Mucosal SIV-Specific Effector Memory T Lymphocyte Responses Elicited by Recombinant Adenovirus Vectors in Rhesus Monkeys.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TROTT KA , Chau JY, Hudgens MG, Fine J, et al
Evidence for an Increased Risk of SIV and Malaria Transmission in a Rhesus Macaque Co-Infection Model.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DATTA SA , Zuo X, Clark PK, Campbell SJ, et al
Solution Properties of Murine Leukemia Virus Gag Protein: Differences from HIV-1 Gag.
J Virol. 2011.
PubMed Text format Related articles Abstract available

JANAKA SK , Lucas T, Johnson MC
SEQUENCES IN GIBBON APE LEUKEMIA VIRUS ENVELOPE THAT CONFER SENSITIVITY TO HIV-1 ACCESSORY PROTEIN VPU.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WONDERLICH ER , Leonard JA, Kulpa DA, Leopold KE, et al
ARF-1 activity is required to recruit AP-1 to the MHC-I cytoplasmic tail and disrupt MHC-I trafficking in HIV-1 infected primary T cells.
J Virol. 2011.
PubMed Text format Related articles Abstract available

EL-HAGE N , Dever SM, Fitting S, Ahmed T, et al
HIV-1 co-infection and morphine co-exposure severely dysregulate HCV-induced hepatic pro-inflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host-defenses.
J Virol. 2011.
PubMed Text format Related articles Abstract available

August 2011

SHAW JM , Hunt PW, Critchfield JW, McConnell DH, et al
Increased Frequency of Regulatory T-Cells Accompanies Increased T-Cell Immune Activation in Rectal Mucosa of HIV+ Non-Controllers.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ZHU Z , Qin HR, Chen W, Zhao Q, et al
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ONIANGUE-NDZA C , Kuntzen T, Kemper M, Berical A, et al
Compensatory Mutations Restore the Replication Defects Caused by CTL Escape Mutations in HCV Polymerase.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ST-PIERRE C , Manya H, Ouellet M, Clark GF, et al
HOST SOLUBLE GALECTIN-1 PROMOTES HIV-1 REPLICATION THROUGH A DIRECT INTERACTION WITH GLYCANS OF VIRAL GP120 AND HOST CD4.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TANDON R , Sengupta D, Ndhlovu LC, Vieira RG, et al
Identification of Human Endogenous Retrovirus (HERV)-specific T Cell Responses in Vertically HIV-1-Infected Subjects.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LIU P , Overman RG, Yates NL, Alam SM, et al
Dynamic Antibody Specificities and Virion Concentrations in Circulating Immune Complexes in Acute to Chronic HIV-1 Infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GOMEZ CE , Najera JL, Perdiguero B, Garcia-Arriaza J, et al
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional and selective effector memory T cell responses to HIV-1 antigens.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KHATTAR SK , Samal S, Devico AL, Collins PL, et al
Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in guinea pigs.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LU L , Palaniyandi S, Zeng R, Bai Y, et al
An FcRn-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KUNIHOLM MH , Gao X, Xue X, Kovacs A, et al
Human Leukocyte Antigen (HLA) Genotype and Risk of HIV Disease Progression Before and After Initiation of Antiretroviral Therapy.
J Virol. 2011.
PubMed Text format Related articles Abstract available

HOMANN S , Smith D, Little S, Richman D, et al
Upregulation of BST-2/tetherin by HIV infection in vivo.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TOMARAS GD , Binley JM, Gray ES, Crooks ET, et al
Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-infected Individuals.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MOLDT B , Schultz N, Dunlop DC, Alpert MD, et al
A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fc{gamma}Rs to define the role of Effector Functions in Protection against HIV.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DILLEY KA , Ni N, Nikolaitchik OA, Chen J, et al
Determining the Frequency and Mechanisms of HIV-1 and HIV-2 RNA Copackaging by Single Virion Analysis.
J Virol. 2011.
PubMed Text format Related articles Abstract available

XU HT , Asahchop EL, Oliveira M, Quashie PK, et al
Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase of Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations.
J Virol. 2011.
PubMed Text format Related articles Abstract available

HANLEY TM , Viglianti GA
Nuclear Receptor Signaling Inhibits HIV-1 Replication in Macrophages through Multiple trans-repression Mechanisms.
J Virol. 2011.
PubMed Text format Related articles Abstract available

HAAS A , Zimmermann K, Oxenius A
ANTIGEN-DEPENDENT AND -INDEPENDENT MECHANISMS OF T AND B CELL HYPERACTIVATION DURING CHRONIC HIV-1 INFECTION.
J Virol. 2011.
PubMed Text format Related articles Abstract available

HU Z , Kuritzkes DR
Interaction of reverse transcriptase (RT) mutations conferring resistance to lamivudine and etravirine: effects on fitness and RT activity of human immunodeficiency virus type 1.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MURRAY JM , Kelleher AD, Cooper DA
Timing of the Components of the HIV Life Cycle in Productively Infected CD4+ T Cells in Populations of HIV Infected Individuals.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CASHIN K , Roche M, Sterjovski J, Ellett A, et al
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DUGGAL NK , Malik HS, Emerman M
Positive selection of Apobec3DE in chimpanzees has driven breadth in anti-viral activity.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GANUSOV VV , Goonetilleke N, Liu MK, Ferrari G, et al
Fitness costs and diversity of CTL response determine the rate of CTL escape during the acute and chronic phases of HIV infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

EGGINK D , Bontjer I, Langedijk JP, Berkhout B, et al
Human immunodeficiency virus type 1 resistance to a third generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WANG J , Zhang G, Bambara RA, Li D, et al
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-resistant Virus is Stimulated by Efavirenz (EFV) During Early Stages of Infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

HULTQUIST JF , Lengyel JA, Refsland EW, Larue RS, et al
Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity to Restrict Vif-deficient HIV-1.
J Virol. 2011.
PubMed Text format Related articles Abstract available

JIANG C , Parrish NF, Wilen CB, Li H, et al
Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MEDITZ AL , Haas MK, Folkvord JM, Melander K, et al
HLA-DR+CD38+CD4+ T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-tropic HIV-1 RNA in Vivo.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LAU D , Kwan W, Guatelli J
Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KOH Y , Aoki M, Danish ML, Aoki-Ogata H, et al
LOSS OF DARUNAVIR'S PROTEASE DIMERIZATION INHIBITION ACTIVITY IS ASSOCIATED WITH HIV-1 ACQUISITION OF RESISTANCE TO DARUNAVIR.
J Virol. 2011.
PubMed Text format Related articles Abstract available

HOGUE IB , Grover JR, Soheilian F, Nagashima K, et al
Gag Induces the Coalescence of Clustered Lipid Rafts and Tetraspanin-Enriched Microdomains at HIV-1 Assembly Sites on the Plasma Membrane.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CHAN J , Dick RA, Vogt VM
Rous sarcoma virus Gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.
J Virol. 2011.
PubMed Text format Related articles Abstract available

NISHIMURA Y , Shingai M, Lee WR, Sadjadpour R, et al
Recombination Mediated Changes in Coreceptor Usage Confers an Augmented Pathogenic Phenotype in a Non-human Primate Model of HIV-1 Induced AIDS.
J Virol. 2011.
PubMed Text format Related articles Abstract available

July 2011

SPIVAK AM , Salgado M, Rabi SA, O'Connell KA, et al
Circulating Monocytes Are Not a Major Reservoir of HIV-1 in Elite Suppressors.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GONZALEZ-ALBA JM , Holguin A, Garcia R, Garcia-Bujalance S, et al
Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis.
J Virol. 2011.
PubMed Text format Related articles Abstract available

VARELA M , Landskron L, Lai RP, McKinley TJ, et al
Molecular evolution analysis of the Human Immunodeficiency Virus type 1 envelope in SHIV-infected macaques: implications for challenge dose selection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BONSIGNORI M , Hwang KK, Chen X, Tsao CY, et al
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ZOLLA-PAZNER S , Kong XP, Jiang X, Cardozo T, et al
CROSS-CLADE HIV-1 NEUTRALIZING ANTIBODIES INDUCED WITH V3-SCAFFOLD PROTEIN IMMUNOGENS FOLLOWING PRIMING WITH gp120 DNA.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DIETRICH EA , Brennan G, Ferguson B, Wiseman RW, et al
Variable prevalence and functional diversity of the antiretroviral restriction factor TRIMCyp in Macaca fascicularis.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GUO J , Wang W, Yu D, Wu Y, et al
Spinoculation triggers dynamic actin and cofilin activity facilitating HIV-1 infection of transformed and resting CD4 T cells.
J Virol. 2011.
PubMed Text format Related articles Abstract available

VIGAN R , Neil SJ
SEPARABLE DETERMINANTS OF SUBCELLULAR LOCALIZATION AND INTERACTION ACCOUNT FOR THE INABILITY OF GROUP O HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) VPU TO COUNTERACT TETHERIN.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WILSON JJ , Lin E, Pack CD, Frost EL, et al
IFN-{gamma} Controls Mouse Polyomavirus Infection In Vivo.
J Virol. 2011.
PubMed Text format Related articles Abstract available

YEH WW , Rao SS, Lim SY, Zhang J, et al
TRIM5 modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys.
J Virol. 2011.
PubMed Text format Related articles Abstract available

PERREAU M , Welles HC, Harari A, Hall O, et al
DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell responses in Intestinal Mucosa.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SHINGAI M , Yoshida T, Martin MA, Strebel K, et al
SOME HIV-1 VPU PROTEINS ARE ABLE TO ANTAGONIZE MACAQUE BST-2 IN VITRO AND IN VIVO: VPU NEGATIVE SHIVS ARE ATTENUATED IN VIVO.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MARTIN KL , Johnson M, D'Aquila RT
APOBEC3G Complexes Decrease Human Immunodeficiency Virus Type 1 (HIV-1) Production.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DAS AT , Harwig A, Berkhout B
The HIV-1 Tat protein has a versatile role in activating viral transcription.
J Virol. 2011.
PubMed Text format Related articles Abstract available

EISFELD AJ , Neumann G, Kawaoka Y
HRB is Essential for Influenza A Virus Replication and Promotes Genome Trafficking in Late-Stage Infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WU W , Blythe DC, Loyd H, Mealey RH, et al
Decreased infectivity of a neutralization-resistant equine infectious anemia virus variant can be overcome by efficient cell-to-cell spread.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BERGER CT , Frahm N, Price DA, Mothe B, et al
High functional avidity CTL responses to HLA-B-restricted Gag-derived epitopes associate with relative HIV control.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WILKS AB , Perry JR, Ehlinger EP, Zahn RC, et al
High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus (SIV)-infected African green monkeys.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LIENLAF M , Hayashi F, Di Nunzio F, Tochio N, et al
Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5{alpha}rh: Structure of the RING domain of TRIM5{alpha}
J Virol. 2011.
PubMed Text format Related articles Abstract available

FOUDA GG , Yates NL, Pollara J, Shen X, et al
HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BUZON MJ , Seiss K, Weiss R, Brass AL, et al
Inhibition of HIV-1 integration in ex vivo infected CD4 T cells from elite controllers.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TANG H , Robinson JE, Gnanakaran S, Li M, et al
Epitopes Immediately Below the Base of the V3 Loop of gp120 as Targets for the Initial Autologous Neutralizing Antibody Response in Two HIV-1 Subtype B-Infected Individuals.
J Virol. 2011.
PubMed Text format Related articles Abstract available

June 2011

WILEN CB , Parrish NF, Pfaff JM, Decker JM, et al
Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins.
J Virol. 2011.
PubMed Text format Related articles Abstract available

PAK V , Heidecker G, Pathak VK, Derse D, et al
The Role of Amino-Terminal Sequences in Cellular Localization and Anti-Viral Activity of APOBEC3B.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LIU L , Wen M, Wang W, Wang S, et al
Potent and broad anti-HIV-1 activity exhibited by a GPI-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CHEN W , Feng Y, Gong R, Zhu Z, et al
Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogens.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TANG J , Cormier E, Gilmour J, Price MA, et al
Human Leukocyte Antigen Variants B*44 and B*57 Are Consistently Favorable during Two Distinct Phases of Primary HIV-1 Infection in Sub-Saharan Africans with Several Viral Subtypes.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LI Y , O'Dell S, Walker LM, Wu X, et al
Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.
J Virol. 2011.
PubMed Text format Related articles Abstract available

QUEEN SE , Mears BM, Kelly KM, Dorsey JL, et al
Replication competent SIV Gag escape mutations archived in latent reservoirs during anti-retroviral treatment of SIV-infected macaques.
J Virol. 2011.
PubMed Text format Related articles Abstract available

FRIEDMAN J , Cho WK, Chu CK, Keedy KS, et al
Epigenetic silencing of HIV-1 by the Histone H3 lysine 27 Methyltransferase Enhancer of Zeste 2 (EZH2).
J Virol. 2011.
PubMed Text format Related articles Abstract available

EBRAHIMI D , Anwar F, Davenport MP
APOBEC3 has not Left an Evolutionary Footprint on the HIV-1 Genome.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SIVARAMAN V , Zhang L, Su L
Type 1 interferon contributes to CD4+ T cell depletion in HIV-1 induced human thymus.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LIN PH , Ke YY, Su CT, Shiao HY, et al
Inhibition of HIV-1 Tat-mediated transcription by a Coumarin derivative BPRHIV001 through Akt Pathway.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ALEXANDRE KB , Gray ES, Pantophlet R, Moore PL, et al
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BERRO R , Klasse PJ, Lascano D, Flegler A, et al
Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KIM J , Tipper C, Sodroski J
Role of the TRIM5{alpha} RING Domain E3 Ubiquitin Ligase Activity in Capsid Disassembly, Reverse Transcription Blockade and Restriction of Simian Immunodeficiency Virus.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SHAHID A , Dixit SM, Gurbacharya VL, Karmacharya D, et al
HIV-1 Circulating Recombinant Form (CRF) in Nepal.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WANG X , Meyers C, Wang HK, Chow LT, et al
Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

VENTER M , van Niekerk S, Rakgantso A, Bent N, et al
Identification of deletion mutant Respiratory Syncytial virus strains lacking most of the G-protein in immunocompromised children with pneumonia in South Africa.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CHAKRABARTI BK , Walker LM, Guenaga JF, Ghobbeh A, et al
Direct Antibody Access to the HIV-1 MPER Positively Correlates with Neutralization Sensitivity.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SAINSKI AM , Natesampillai S, Cummins NW, Bren GD, et al
The HIV-1 specific protein Casp8p41, induces death of infected cells through Bax/Bak.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TAN X , Sande JL, Pufnock JS, Blattman JN, et al
Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LI MM , Emerman M
Polymorphism in human APOBEC3H affects a dominant phenotype of subcellular localization and antiviral activity.
J Virol. 2011.
PubMed Text format Related articles Abstract available

VAN GILS MJ , Edo-Matas D, Bowles EJ, Burger JA, et al
Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GO EP , Hewawasam G, Liao HX, Chen H, et al
Characterization of Glycosylation Profiles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CONG ME , Youngpairoj AS, Zheng Q, Aung W, et al
Protection against Rectal Transmission of an Emtricitabine (FTC)-Resistant SHIV162p3M184V Mutant by Intermittent Prophylaxis with Truvada.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SUSPENE R , Aynaud MM, Koch S, Pasdeloup D, et al
Genetic editing of Herpes Simplex 1 and Epstein Barr herpesvirus genomes by human APOBEC-3 cytidine deaminases in culture and in vivo.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BATTIVELLI E , Migraine J, Lecossier D, Matsuoka S, et al
Modulation of TRIM5{alpha} activity in human cells by alternatively spliced TRIM5 isoforms.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GIANELLA S , Delport W, Pacold ME, Young JA, et al
Detection of Minority Resistance during Early HIV-1 Infection: Natural Variation and Spurious Detection Rather than Transmission and Evolution of Multiple Viral Variants.
J Virol. 2011.
PubMed Text format Related articles Abstract available

OGAWA T , Tsuji-Kawahara S, Yuasa T, Kinoshita S, et al
Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.
J Virol. 2011;85:5423-35.
PubMed Text format Related articles Abstract available

May 2011

NI N , Nikolaitchik OA, Dilley KA, Chen J, et al
Mechanisms of Human Immunodeficiency Virus Type 2 RNA Packaging: Efficient Trans Packaging and Selection of RNA Copackaging Partners.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TAYLOR HE , Linde ME, Khatua AK, Popik W, et al
SREBP2 Couples HIV-1 Transcription to Cholesterol Homeostasis and T Cell Activation.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CHOPERA DR , Mlotshwa M, Woodman Z, Mlisana K, et al
Virological and Immunological Factors Associated with HIV-1 Differential Disease Progression in HLA-B*58:01 Positive Individuals.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WELSCH S , Groot F, Krausslich HG, Keppler OT, et al
Architecture and Regulation of the HIV-1 Assembly and Holding Compartment in Macrophages.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GRAY ES , Moody MA, Wibmer CK, Chen X, et al
Isolation of a monoclonal antibody targeting the alpha-2 helix of gp120 representing the initial autologous neutralizing antibody response in an HIV-1 subtype C infected individual.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KWONG JA , Dorfman T, Quinlan BD, Chiang JJ, et al
A tyrosine-sulfated CCR5-mimetic peptide promotes conformational transitions in the HIV-1 envelope glycoprotein.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SUN Y , Asmal M, Lane S, Permar SR, et al
Antibody-Dependent Cell-Mediated Cytotoxicity in Simian Immunodeficiency Virus-Infected Rhesus Monkeys.
J Virol. 2011.
PubMed Text format Related articles Abstract available

JIN J , Li F, Mothes W
Viral determinants of polarized assembly for the murine leukemia virus.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DENTON PW , Othieno F, Martinez-Torres F, Zou W, et al
Topically Applied 1% Tenofovir in Humanized BLT Mice Using the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection Validating the BLT Model for the Evaluation of New Microbicide Candidates.
J Virol. 2011.
PubMed Text format Related articles Abstract available

RUSSELL ES , Kwiek JJ, Keys J, Barton K, et al
The Genetic Bottleneck in Vertical Transmission of Subtype C HIV-1 Is Not Driven by Selection of Especially Neutralization Resistant Virus from the Maternal Viral Population.
J Virol. 2011.
PubMed Text format Related articles Abstract available

HERBECK JT , Rolland M, Liu Y, McLaughlin S, et al
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MUDD PA , Ericsen AJ, Price AA, Wilson NA, et al
Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers.
J Virol. 2011.
PubMed Text format Related articles Abstract available

VAN GILS MJ , Bunnik EM, Boeser-Nunnink BD, Burger JA, et al
Longer V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MATREYEK KA , Engelman A
The Requirement for Nucleoporin NUP153 During Human Immunodeficiency Virus Type 1 Infection is Determined by the Viral Capsid.
J Virol. 2011.
PubMed Text format Related articles Abstract available

EULER Z , Bunnik EM, Burger JA, Boeser-Nunnink BD, et al
Activity of broadly neutralizing antibodies, including PG9, PG16 and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LIU J , Dai L, Qi J, Gao F, et al
Diverse peptide presentation of rhesus macaque MHC class I Mamu-A*02 revealed by two peptide-complex structures and insights into SIV immune escape.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ROTH SL , Malani N, Bushman FD
Gammaretroviral integration into nucleosomal target DNA in vivo.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KUMAR SB , Handelman SK, Voronkin I, Mwapasa V, et al
DIFFERENT REGIONS OF HIV-1 SUBTYPE C ENV ARE ASSOCIATED WITH PLACENTAL LOCALIZATION AND IN UTERO MOTHER-TO-CHILD TRANSMISSION.
J Virol. 2011.
PubMed Text format Related articles

DAVENPORT TM , Friend D, Ellingson K, Xu H, et al
Binding interactions between soluble HIV envelope glycoproteins and quaternary-structure-specific MAbs PG9 and PG16.
J Virol. 2011.
PubMed Text format Related articles

MEDINA GN , Ehrlich LS, Chen MH, Khan MB, et al
Sprouty2 Binds ESCRT-II factor Eap20 and Facilitates HIV-1 Gag Release.
J Virol. 2011.
PubMed Text format Related articles

FERRARI G , Pollara J, Kozink D, Harms T, et al
A HIV-1 gp120 Envelope Human Monoclonal Antibody that Recognizes a C1 Conformational Epitope Mediates Potent ADCC Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum.
J Virol. 2011.
PubMed Text format Related articles

KLEIN KC , Reed JC, Tanaka M, Nguyen VT, et al
HIV Gag-Leucine zipper chimeras form ABCE1-containing intermediates and RNAse-resistant immature capsids similar to those formed by wild-type HIV-1 Gag.
J Virol. 2011.
PubMed Text format Related articles

DEL PORTILLO A , Tripodi J, Najfeld V, Wodarz D, et al
Multiploid inheritance of HIV-1 during cell-to-cell infection.
J Virol. 2011.
PubMed Text format Related articles

LEONARD JA , Filzen T, Carter CC, Schaefer M, et al
HIV-1 Nef disrupts intracellular trafficking of MHC-I, CD4, CD8, and CD28 by distinct pathways that share common elements.
J Virol. 2011.
PubMed Text format Related articles

KOEDEL Y , Eissmann K, Wend H, Fleckenstein B, et al
Peptides derived from a distinct region of GB Virus C glycoprotein E2 mediate strain specific HIV-1 entry inhibition.
J Virol. 2011.
PubMed Text format Related articles

HU QY , Fink E, Happer M, Elder JH, et al
Identification of Amino Acid Residues Important for Heparan Sulfate Proteoglycan (HSPG) Interaction within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein.
J Virol. 2011.
PubMed Text format Related articles

April 2011

GARCIA-LERMA JG , Aung W, Cong ME, Zheng Q, et al
Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors.
J Virol. 2011.
PubMed Text format Related articles

SENGUPTA D , Tandon R, Vieira RG, Ndhlovu LC, et al
Strong human endogenous retrovirus (HERV)-specific T cell responses are associated with control of HIV-1 in chronic infection.
J Virol. 2011.
PubMed Text format Related articles

SUNSERI N , O'Brien M, Bhardwaj N, Landau NR, et al
HIV-1 modified to package SIV Vpx efficiently infects macrophages and dendritic cells.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LEFEBVRE G , Desfarges S, Uyttebroeck F, Munoz M, et al
Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DIETRICH I , McMonagle EL, Petit S, Vijayakrishnan S, et al
Feline tetherin (BST-2) efficiently restricts feline immunodeficiency virus release but not spreading infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WANG D , Hicks CB, Goswami N, Tafoya E, et al
Evolution of Drug-resistant Viral Populations during Interruption of Antiretroviral Therapy.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MORNER A , Jansson M, Bunnik EM, Scholler J, et al
Immunization with Recombinant HLA Class I and II, HIV-1 gp140 and SIV p27 Elicits Protection against Heterologous SHIV Infection in Rhesus Macaques.
J Virol. 2011.
PubMed Text format Related articles Abstract available

GELINAS JF , Clerzius G, Shaw E, Gatignol A, et al
ADAR1 enhancement of replication of RNA viruses via RNA editing and inhibition of PKR.
J Virol. 2011.
PubMed Text format Related articles Abstract available

PETTERSEN FO , Torheim EA, Dahm AE, Aaberge IS, et al
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: Downregulated immune activation and improved T cell-dependent vaccine responses.
J Virol. 2011.
PubMed Text format Related articles Abstract available

FADDA L , O'Connor G, Kumar S, Trocha A, et al
Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules.
J Virol. 2011.
PubMed Text format Related articles Abstract available

XING S , Bullen CK, Shroff NS, Shan L, et al
Disulfiram reactivates latent HIV-1 in a Bcl-2 transduced primary CD4+ T cell model without inducing global T cell activation.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CROOKS ET , Tong T, Osawa K, Binley JM, et al
Enzyme Digests Eliminate Non-Functional Env from HIV-1 Particle Surfaces Leaving Native Env Trimers Intact and Viral Infectivity Unaffected.
J Virol. 2011.
PubMed Text format Related articles Abstract available

MEDINA-RAMIREZ M , Sanchez-Merino V, Sanchez-Palomino S, Merino-Mansilla A, et al
Broadly Cross-Neutralizing Antibodies in HIV-1 Patients with Undetectable Viremia.
J Virol. 2011.
PubMed Text format Related articles Abstract available

KAMYA P , Boulet S, Tsoukas CM, Routy JP, et al
Receptor-ligand requirements for increased NK cell poly-functional potential in *h/*y+B57 HIV-1 infected Slow progressors.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CICCONE EJ , Greenwald JH, Lee PI, Biancotto A, et al
CD4+ T Cells, Including Th17 and Cycling Subsets, are Intact in the Gut Mucosa of HIV-1 Infected Long-Term Non- Progressors.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BROWN RJ , Peters PJ, Caron C, Gonzalez-Perez MP, et al
Inter-compartment recombination of HIV-1 contributes to env intra-host diversity and modulates viral tropism and senstivity to entry inhibitors.
J Virol. 2011.
PubMed Text format Related articles Abstract available

APARICIO E , Franco S, Parera M, Andres C, et al
Hepatitis C virus NS3/4A protease quasispecies complexity and catalytic efficiency influence responsiveness to peginterferon plus ribavirin treatment in HCV/HIV-co-infected patients.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TASCA S , Zhuang K, Gettie A, Knight H, et al
Effect of B-cell depletion on coreceptor switching in R5 simian-human immunodeficiency virus infection of rhesus macaques.
J Virol. 2011;85:3086-94.
PubMed Text format Related articles Abstract available

March 2011

ASMAL M , Sun Y, Lane S, Yeh W, et al
Antibody-dependent cell-mediated viral inhibition emerges after SIVmac251 infection of rhesus monkeys coincident with gp140 binding antibodies and is effective against neutralization-resistant viruses.
J Virol. 2011.
PubMed Text format Related articles Abstract available

TOMITA Y , Noda T, Fujii K, Watanabe T, et al
The cellular factors Vps18 and Mon2 are required for efficient production of infectious HIV-1 particles.
J Virol. 2011.
PubMed Text format Related articles Abstract available

CHAHROUDI A , Meeker T, Lawson B, Ratcliffe S, et al
Mother-to-infant transmission of SIV is rare in sooty mangabeys and is associated with low viremia.
J Virol. 2011.
PubMed Text format Related articles Abstract available

DANG Y , Abudu A, Son S, Harjes E, et al
Identification of a Single Amino Acid Required for APOBEC3 Antiretroviral Cytidine Deaminase Activity.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SHAN L , Yang HC, Rabi SA, Bravo HC, et al
Influence of host gene transcription level and orientation on HIV-1 latency in a primary cell model.
J Virol. 2011.
PubMed Text format Related articles Abstract available

BRACKENRIDGE S , Evans EJ, Toebes M, Goonetilleke N, et al
An early HIV mutation within a HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1 (KIR3DL1).
J Virol. 2011.
PubMed Text format Related articles Abstract available

MALHERBE DC , Doria-Rose NA, Misher L, Beckett T, et al
Sequential immunization with a subtype B HIV-1 Envelope quasispecies partially mimics the in vivo development of neutralizing antibodies.
J Virol. 2011.
PubMed Text format Related articles Abstract available

WANG XM , Nadeau PE, Lin S, Abbott JR, et al
Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-{kappa}B.
J Virol. 2011.
PubMed Text format Related articles Abstract available

VAINE M , Duenas-Decamp M, Peters P, Liu Q, et al
Two Closely Related Env Antigens from the Same Patient Elicited Different Spectrum of Neutralizing Antibodies Against Heterologous HIV-1 Viral Isolates.
J Virol. 2011.
PubMed Text format Related articles Abstract available

SINGER R , Derby N, Rodriguez A, Kizima L, et al
An NNRTI MIV-150/carrageenan gel prevents rectal immunodeficiency virus infection in macaques.
J Virol. 2011.
PubMed Text format Related articles Abstract available

LYNCH JB , Nduati R, Blish CA, Richardson BA, et al
The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies does not correlate with risk of infant infection.
J Virol. 2011.
PubMed Text format Related articles Abstract available

ELLER MA , Koehler RN, Kijak GH, Eller LA, et al
Human Immunodeficiency Virus Type 1 Infection is Associated with Increased NK Cell Polyfunctionality and Higher Levels of KIR3DL1+ NK Cells in Ugandans Carrying the HLA-B Bw4 Motif.
J Virol. 2011.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.
Design: